GlassScriptPhysician profile
Anthony Joseph Ascioti
NPI 1386689776
$9,369.18
in general payments reported to CMS, 2019-2025
10 companies · $6,468 in 2025
The $6,468 reported for 2025 was more than what 85% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $37.07 · 2021: $329 · 2022: $63.73 · 2023: $129 · 2024: $1,420 · 2025: $6,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,200 · Travel and Lodging: $1,065 · Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,200.00 |
| Travel and Lodging | $1,064.87 |
| Food and Beverage | $752.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $6,382.94 | 2025 | |
| Intuitive Surgical, INC. | $1,469.70 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $567.51 | 2019-2025 | Ribfix Titan |
| Ethicon INC. | $397.60 | 2019 | |
| Medtronic, INC. | $304.46 | 2024 | Signia, Endoflip, Progrip |
| E.R. Squibb & Sons, L.L.C. | $129.00 | 2023 | Opdivo |
| Depuy Synthes Sales INC. | $64.00 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $25.54 | 2019-2022 | |
| On Target Laboratories, INC | $15.75 | 2024 | Cytalux |
| Biohaven Pharmaceutical Holding Company LTD. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Ascioti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.